Open Heart

SEPTEMBER 4, 2023

Introduction Severe aortic stenosis is a major cause of morbidity and mortality. The existing treatment pathway for transcatheter aortic valve implantation (TAVI) traditionally relies on tertiary Heart Valve Centre workup. Methods The centre performing local workup implemented a novel TAVI referral pathway.

Heart Valves 52

Heart Valves Aortic valve Aortic Outpatient 52

Open Heart

MARCH 3, 2025

Background In congenital aortic stenosis (CAS), commissurotomy is an option in patients not suitable to receive a valve prosthesis. However, there is often a need for future additional interventions on the aortic valve. The fate of the aortic valve is, however, essentially unknown.

Congenital 52

Congenital Stenosis Aortic Aortic valve 52

Frontiers in Cardiovascular Medicine

JANUARY 23, 2024

Aims The majority of patients with severe aortic stenosis (AS) planned for transcatheter aortic valve implantation (TAVI) are elective outpatients. During the COVID-19 pandemic, the time between the heart team’s decision and TAVI increased due to limited healthcare resources.

Aortic valve 53

Aortic valve Aortic COVID-19 Blood Pressure 53